盛和資源(600392.SH):擬申請註冊發行不超15億元中期票據
格隆匯3月18日丨盛和資源(600392.SH)公佈,為滿足盛和資源控股股份有限公司經營發展需要,拓寬融資渠道,優化債務結構,公司於2022年3月18日召開第七屆董事會第二十三次會議,審議通過了《關於發行中期票據的議案》,公司擬向中國銀行間市場交易商協會申請註冊發行總規模為不超過人民幣15億元的中期票據。
期限最長不超過7年,可以是單一期限品種,也可以是多種期限品種的組合,具體期限構成和各期限工具的發行規模根據相關規定及市場情況確定。
本次中期票據的募集資金將用於償還有息債務、補充流動資金、項目投資或股權投資等符合監管要求的相應用途,具體募集資金用途於註冊及發行時根據公司資金需求確定。
決議有效期自該議案獲得公司股東大會批准之日起36個月內有效。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.